We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca Appeals Toprol-XL Patent Invalidity

Law360 (February 16, 2006, 12:00 AM EST) -- Pharmaceutical company AstraZeneca PLC is appealing a federal court ruling that scuttled its patents for the valuable heart drug Toprol-XL and threatened its pipeline of branded drugs.

AstraZeneca, the third largest...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.